Atea Pharmaceuticals, Inc.
AVIR
$6.00
$0.091.52%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 24.49% | 18.18% | |||
| Gross Profit | -24.49% | -18.18% | |||
| SG&A Expenses | -1.44% | -20.40% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.37% | 9.73% | |||
| Operating Income | -20.37% | -9.73% | |||
| Income Before Tax | -23.37% | -13.26% | |||
| Income Tax Expenses | -3,553.06% | -5.31% | |||
| Earnings from Continuing Operations | -6.70% | -13.15% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -6.70% | -13.15% | |||
| EBIT | -20.37% | -9.73% | |||
| EBITDA | -20.42% | -9.76% | |||
| EPS Basic | -7.97% | -19.88% | |||
| Normalized Basic EPS | -24.64% | -19.39% | |||
| EPS Diluted | -7.97% | -19.88% | |||
| Normalized Diluted EPS | -24.64% | -19.39% | |||
| Average Basic Shares Outstanding | -1.17% | -5.61% | |||
| Average Diluted Shares Outstanding | -1.17% | -5.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||